Malignant progression of preleukemic disorders

2.

Wlodarski

MW

,

Hirabayashi

S

,

Pastor

V

, et al.

Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

.

Blood

.

2016

;

127

(

11

):

1387

-

1397

.

3.

Sahoo

SS

,

Kozyra

EJ

,

Wlodarski

MW

.

Germline predisposition in myeloid neoplasms: unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes

.

Best Pract Res Clin Haematol

.

2020

;

33

(

3

):

101197

.

4.

Schwartz

JR

,

Ma

J

,

Lamprecht

T

, et al.

The genomic landscape of pediatric myelodysplastic syndromes

.

Nat Commun

.

2017

;

8

(

1

):

1557

.

5.

Sahoo

SS

,

Pastor

VB

,

Goodings

C

, et al.

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

.

Nat Med

.

2021

;

27

(

10

):

1806

-

1817

.

6.

Tsai

F-Y

,

Keller

G

,

Kuo

FC

, et al.

An early hematopoietic defect in mice lacking the transcription factor GATA-2

.

Nature

.

1994

;

371

(

6494

):

221

-

226

.

7.

Hahn

CN

,

Chong

CE

,

Carmichael

CL

, et al.

Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia

.

Nat Genet

.

2011

;

43

(

10

):

1012

-

1017

.

8.

Hsu

AP

,

Sampaio

EP

,

Khan

J

, et al.

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome

.

Blood

.

2011

;

118

(

10

):

2653

-

2655

.

9.

Ostergaard

P

,

Simpson

MA

,

Connell

FC

, et al.

Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)

.

Nat Genet

.

2011

;

43

(

10

):

929

-

931

.

10.

Dickinson

RE

,

Griffin

H

,

Bigley

V

, et al.

Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency

.

Blood

.

2011

;

118

(

10

):

2656

-

2658

.

11.

Narumi

S

,

Amano

N

,

Ishii

T

, et al.

SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7

.

Nat Genet

.

2016

;

48

(

7

):

792

-

797

.

12.

Buonocore

F

,

Kuhnen

P

,

Suntharalingham

JP

, et al.

Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans

.

J Clin Invest

.

2017

;

127

(

5

):

1700

-

1713

.

13.

Chen

DH

,

Below

JE

,

Shimamura

A

, et al.

Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L

.

Am J Hum Genet

.

2016

;

98

(

6

):

1146

-

1158

.

14.

Tesi

B

,

Davidsson

J

,

Voss

M

, et al.

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms

.

Blood

.

2017

;

129

(

16

):

2266

-

2279

.

15.

Pastor

VB

,

Sahoo

SS

,

Boklan

J

, et al.

Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7

.

Haematologica

.

2018

;

103

(

3

):

427

-

437

.

16.

Wong

JC

,

Bryant

V

,

Lamprecht

T

, et al.

Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes

.

JCI Insight

.

2018

;

3

(

14

):

e121086

.

17.

Bluteau

O

,

Sebert

M

,

Leblanc

T

, et al.

A landscape of germ line mutations in a cohort of inherited bone marrow failure patients

.

Blood

.

2018

;

131

(

7

):

717

-

732

.

18.

Hasle

H

,

Friedman

JM

,

Olsen

JH

,

Rasmussen

SA

.

Low risk of solid tumors in persons with Down syndrome

.

Genet Med

.

2016

;

18

(

11

):

1151

-

1157

.

19.

Boucher

AC

,

Caldwell

KJ

,

Crispino

JD

,

Flerlage

JE

.

Clinical and biological aspects of myeloid leukemia in Down syndrome

.

Leukemia

.

2021

;

35

(

12

):

3352

-

3360

.

20.

Mundschau

G

,

Gurbuxani

S

,

Gamis

AS

,

Greene

ME

,

Arceci

RJ

,

Crispino

JD

.

Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis

.

Blood

.

2003

;

101

(

11

):

4298

-

4300

.

21.

Labuhn

M

,

Perkins

K

,

Matzk

S

, et al.

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome

.

Cancer Cell

.

2019

;

36

(

2

):

123

-

138.e10

.

22.

Yoshida

K

,

Toki

T

,

Okuno

Y

, et al.

The landscape of somatic mutations in Down syndrome-related myeloid disorders

.

Nat Genet

.

2013

;

45

(

11

):

1293

-

1299

.

23.

Roberts

I

,

Alford

K

,

Hall

G

, et al.

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia

.

Blood

.

2013

;

122

(

24

):

3908

-

3917

.

24.

Steensma

DP

.

Clinical consequences of clonal hematopoiesis of indeterminate potential

.

Blood Adv

.

2018

;

2

(

22

):

3404

-

3410

.

25.

DeZern

A

,

Malcovati

L

,

Ebert

B

.

CHIP, CCUS, and other acronyms: definition, implications, and impact on practice

.

Am Soc Clin Oncol Educ Book

.

2019

;

39

:

400

-

410

.

26.

Malcovati

L

,

Cazzola

M

.

The shadowlands of MDS: idiopathic cytopenia’s of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)

.

Hematology Am Soc Hematol Educ Program

.

2015

;

2015

(

1

):

299

-

307

.

27.

Malcovati

L

,

Galli

A

,

Travaglino

E

, et al.

Clinical significance of somatic mutation in unexplained blood cytopenia

.

Blood

.

2017

;

129

(

25

):

3371

-

3378

.

28.

Warren

JT

,

Link

DC

.

Clonal hematopoiesis and risk for hematologic malignancy

.

Blood

.

2020

;

136

(

14

):

1599

-

1605

.

29.

Arber

DA

,

Orazi

A

,

Hasserjian

RP

, et al.

International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data

.

Blood

.

2022

;

140

(

11

):

1200

-

1228

.

30.

Donadieu

J

,

Lamant

M

,

Fieschi

C

, et al.

Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients

.

Haematologica

.

2018

;

103

(

8

):

1278

-

1287

.

31.

McReynolds

LJ

,

Yang

Y

,

Yuen Wong

H

, et al.

MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations

.

Leuk Res

.

2019

;

76

:

70

-

75

.

32.

West

RR

,

Calvo

KR

,

Embree

LJ

, et al.

ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome

.

Blood Adv

.

2022

;

6

(

3

):

793

-

807

.

33.

Kozyra

EJ

,

Gohring

G

,

Hickstein

DD

, et al.

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

.

Blood

.

2021

;

138

(

23

):

2441

-

2445

.

34.

Kotmayer

L

,

Romero-Moya

D

,

Marin-Bejar

O

, et al.

GATA2 deficiency and MDS/AML: experimental strategies for disease modelling and future therapeutic prospects

.

Br J Haematol

.

2022

;

199

(

4

):

482

-

495

.

35.

Bodor

C

,

Renneville

A

,

Smith

M

, et al.

Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival

.

Haematologica

.

2012

;

97

(

6

):

890

-

894

.

36.

West

RR

,

Hsu

AP

,

Holland

SM

,

Cuellar-Rodriguez

J

,

Hickstein

DD

.

Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation

.

Haematologica

.

2014

;

99

(

2

):

276

-

281

.

37.

Pastor

V

,

Hirabayashi

S

,

Karow

A

, et al.

Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants

.

Leukemia

.

2017

;

31

(

3

):

759

-

762

.

38.

Largeaud

L

,

Collin

M

,

Monselet

N

, et al.

Somatic genetic alterations predict hematological progression in GATA2 deficiency

.

Haematologica

.

2023

;

108

(

6

):

1515

-

1529

.

39.

Ochi

Y

,

Kon

A

,

Sakata

T

, et al.

Combined ohesin-RUNX1 deficiency synergistically perturbs chromatin looping and causes myelodysplastic syndromes

.

Cancer Discov

.

2020

;

10

(

6

):

836

-

853

.

40.

Mullenders

J

,

Aranda-Orgilles

B

,

Lhoumaud

P

, et al.

Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms

.

J Exp Med

.

2015

;

212

(

11

):

1833

-

1850

.

41.

Wong

JC

,

Zhang

Y

,

Lieuw

KH

, et al.

Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies

.

Blood

.

2010

;

115

(

22

):

4524

-

4532

.

42.

Hasegawa

A

,

Hayasaka

Y

,

Morita

M

, et al.

Heterozygous variants in GATA2 contribute to DCML deficiency in mice by disrupting tandem protein binding

.

Commun Biol

.

2022

;

5

(

1

):

376

.

43.

Chen

J

,

Kao

YR

,

Sun

D

, et al.

Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level

.

Nat Med

.

2019

;

25

(

1

):

103

-

110

.

44.

Hockings

C

,

Gohil

S

,

Dowse

R

, et al.

In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation

.

Br J Haematol

.

2020

;

188

(

4

):

e53

-

e57

.

45.

Abdelhamed

S

,

Thomas

ME

,

Westover

T

, et al.

Mutant Samd9l expression impairs hematopoiesis and induces bone marrow failure in mice

.

J Clin Invest

.

2022

;

132

(

21

):

e158869

.

46.

Viny

AD

,

Ott

CJ

,

Spitzer

B

, et al.

Dose-dependent role of the cohesion complex in normal and malignant hematopoiesis

.

J Exp Med

.

2015

;

212

(

11

):

1819

-

1832

.

47.

Mazumdar

C

,

Shen

Y

,

Xavy

S

, et al.

Leukemia-associated cohesion mutants dominantly enforce stem cell programs and impair human hematopoietic progenitor differentiation

.

Cell Stem Cell

.

2015

;

17

(

6

):

675

-

688

.

48.

Menssen

AJ

,

Walter

MJ

.

Genetics of progression from MDS to secondary leukemia

.

Blood

.

2020

;

136

(

1

):

50

-

60

.

49.

Taskesen

E

,

Havermans

M

,

van Lom

K

, et al.

Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling

.

Blood

.

2014

;

123

(

21

):

3327

-

3335

.

50.

Lindsley

RC

,

Mar

BG

,

Mazzola

E

, et al.

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

.

Blood

.

2015

;

125

(

9

):

1367

-

1376

.

51.

Papaemmanuil

E

,

Gerstung

M

,

Bullinger

L

, et al.

Genomic classification and prognosis in acute myeloid leukemia

.

N Engl J Med

.

2016

;

374

(

23

):

2209

-

2221

.

52.

Gardin

C

,

Pautas

C

,

Fournier

E

, et al.

Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results

.

Blood Adv

.

2020

;

4

(

9

):

1942

-

1949

.

53.

van der Werf

I

,

Wojtuszkiewicz

A

,

Meggendorfer

M

, et al.

Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification

.

Blood Adv

.

2021

;

5

(

17

):

3254

-

3265

.

54.

Gao

Y

,

Jia

M

,

Mao

Y

, et al.

Distinct mutation landscapes between acute myeloid leukemia with myelodysplasia-related changes and de novo acute myeloid leukemia

.

Am J Clin Pathol

.

2022

;

157

(

5

):

691

-

700

.

55.

Jaiswal

S

,

Fontanillas

P

,

Flannick

J

, et al.

Age-related clonal hematopoiesis associated with adverse outcomes

.

N Engl J Med

.

2014

;

371

(

26

):

2488

-

2498

.

56.

Genovese

G

,

Kahler

AK

,

Handsaker

RE

, et al.

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

.

N Engl J Med

.

2014

;

371

(

26

):

2477

-

2487

.

57.

Papaemmanuil

E

,

Gerstung

M

,

Malcovati

L

, et al.

Clinical and biological implications of driver mutations in myelodysplastic syndromes

.

Blood

.

2013

;

122

(

22

):

3616

-

3627

.

58.

Makishima

H

,

Yoshizato

T

,

Yoshida

K

, et al.

Dynamics of clonal evolution in myelodysplastic syndromes

.

Nat Genet

.

2017

;

49

(

2

):

204

-

212

.

59.

Murphy

DM

,

Bejar

R

,

Stevenson

K

, et al.

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes

.

Leukemia

.

2013

;

27

(

10

):

2077

-

2081

.

60.

Takahashi

K

,

Jabbour

E

,

Wang

X

, et al.

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML

.

Leukemia

.

2013

;

27

(

10

):

2081

-

2083

.

61.

Corces-Zimmerman

MR

,

Hong

WJ

,

Weissman

IL

,

Medeiros

BC

,

Majeti

R

.

Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission

.

Proc Natl Acad Sci U S A

.

2014

;

111

(

7

):

2548

-

2553

.

62.

Kim

T

,

Tyndel

MS

,

Kim

HJ

, et al.

The clonal origins of leukemic progression of myelodysplasia

.

Leukemia

.

2017

;

31

(

9

):

1928

-

1935

.

63.

Shiozawa

Y

,

Malcovati

L

,

Galli

A

, et al.

Gene expression and risk of leukemic transformation in myelodysplasia

.

Blood

.

2017

;

130

(

24

):

2642

-

2653

.

64.

Ding

L

,

Ley

TJ

,

Larson

DE

, et al.

Clonal evolution in relapsed acute myeloid leukemia revealed by whole-genome sequencing

.

Nature

.

2012

;

481

(

7382

):

506

-

510

.

65.

Xu

XQ

,

Wang

JM

,

Gao

L

, et al.

Characteristics of acute myeloid leukemia with myelodysplasia-related changes: a retrospective analysis in a cohort of Chinese patients

.

Am J Hematol

.

2014

;

89

(

9

):

874

-

881

.

66.

Klco

JM

,

Spencer

DH

,

Miller

CA

, et al.

Functional heterogeneity of genetically defined subclones in acute myeloid leukemia

.

Cancer Cell

.

2014

;

25

(

3

):

379

-

392

.

67.

Ling

KW

,

Ottersbach

K

,

van Hamburg

JP

, et al.

GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells

.

J Exp Med

.

2004

;

200

(

7

):

871

-

882

.

68.

Rodrigues

NP

,

Janzen

V

,

Forkert

R

, et al.

Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis

.

Blood

.

2005

;

106

(

2

):

477

-

484

.

69.

Rodrigues

NP

,

Boyd

AS

,

Fugazza

C

, et al.

GATA-2 regulates granulocyte-macrophage progenitor cell function

.

Blood

.

2008

;

112

(

13

):

4862

-

4873

.

70.

Nagamachi

A

,

Matsui

H

,

Asou

H

, et al.

Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7

.

Cancer Cell

.

2013

;

24

(

3

):

305

-

317

.

71.

Nagamachi

A

,

Kanai

A

,

Nakamura

M

, et al.

Multiorgan failure with abnormal receptor metabolism in mice mimicking Samd9/9L syndromes

.

J Clin Invest

.

2021

;

131

(

4

):

e140147

.

72.

Obiorah

IE

,

Upadhyaya

KD

,

Calvo

KR

.

Germline predisposition to myeloid neoplasms: diagnostic concepts and classifications

.

Clin Lab Med

.

2023

;

43

(

4

):

615

-

638

.

73.

Taub

J

,

Mundschau

G

,

Ge

Y

, et al.

Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome

.

Blood

.

2004

;

104

(

5

):

1588

-

1589

.

74.

Gialeski

S

,

Mahnken

A

,

Schmid

L

, et al.

GATA1s exerts developmental stage-specific effects in human hematopoiesis

.

Haematologica

.

2018

;

103

(

8

):

e336

-

e340

.

75.

Wagenblast

E

,

Araujo

J

,

Gan

OI

, et al.

Mapping the cellular origin and early evolution of leukemia in Down syndrome

.

Science

.

2021

;

373

(

6551

):

eabf6202

.

76.

Klusmann

JH

,

Godinho

FJ

,

Heitmann

K

, et al.

Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis

.

Genes Dev

.

2010

;

24

(

15

):

1659

-

1672

.

77.

Chen

CC

,

Silberman

RE

,

Ma

D

, et al.

Inherent genome instability underlies trisomy 21-associated myeloid malignancies

.

Leukemia

.

2024

;

38

(

3

):

521

-

529

.

78.

Busque

L

,

Buscarlet

M

,

Mollica

L

,

Levine

RL

.

Concise review: age-related clonal hematopoiesis: stem cells tempting the devil

.

Stem Cells

.

2018

;

36

(

9

):

1287

-

1294

.

79.

Jeong

M

,

Park

HJ

,

Celik

H

, et al.

Loss of Dnmt3a immortalizes hematopoietic stem cells in vivo

.

Cell Rep

.

2018

;

23

(

1

):

1

-

10

.

80.

Quivoron

C

,

Couronne

L

,

Della Valle

V

, et al.

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis

.

Cancer Cell

.

2011

;

20

(

1

):

25

-

38

.

81.

Moran-Crusio

K

,

Reavie

L

,

Shih

A

, et al.

Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation

.

Cancer Cell

.

2011

;

20

(

1

):

11

-

24

.

82.

Vinh

DC

,

Patel

SY

,

Uzel

G

, et al.

Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia

.

Blood

.

2010

;

115

(

8

):

1519

-

1529

.

83.

Mansour

S

,

Connell

F

,

Steward

C

, et al.

Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases

.

Am J Med Genet A

.

2010

;

152A

(

9

):

2287

-

2296

.

84.

Bigley

V

,

Haniffa

M

,

Doulatov

S

, et al.

The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency

.

J Exp Med

.

2011

;

208

(

2

):

227

-

234

.

85.

Mace

EM

,

Hsu

AP

,

Monaco-Shawver

L

, et al.

Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset

.

Blood

.

2013

;

121

(

14

):

2669

-

2677

.

86.

Ganapathi

KA

,

Townsley

DM

,

Hsu

AP

, et al.

GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia

.

Blood

.

2015

;

125

(

1

):

56

-

70

.

87.

Novakova

M

,

Zaliova

M

,

Sukova

M

, et al.

Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome

.

Haematologica

.

2016

;

101

(

6

):

707

-

716

.

88.

Pasquet

M

,

Bellanne-Chantelot

C

,

Tavitian

S

, et al.

High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia

.

Blood

.

2013

;

121

(

5

):

822

-

829

.

89.

Spinner

MA

,

Sanchez

LA

,

Hsu

AP

, et al.

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity

.

Blood

.

2014

;

123

(

6

):

809

-

821

.

90.

Wu

Z

,

Gao

S

,

Diamond

C

, et al.

Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency

.

Blood Adv

.

2020

;

4

(

12

):

2656

-

2670

.

91.

Takai

J

,

Shimada

T

,

Nakamura

T

,

Engel

JD

,

Moriguchi

T

.

Gata2 heterozygous mutant mice exhibit reduced inflammatory responses and impaired bacterial clearance

.

iScience

.

2021

;

24

(

8

):

102836

.

92.

Liu

J

,

Wennier

S

,

Zhang

L

,

McFadden

G

.

M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells

.

J Virol

.

2011

;

85

(

7

):

3270

-

3282

.

93.

Meng

X

,

Zhang

F

,

Yan

B

, et al.

A paralogous pair of mammalian host restriction factors form a critical host barrier against poxvirus infection

.

PLoS Pathog

.

2018

;

14

(

2

):

e1006884

.

94.

Dai

W

,

Cao

D

,

Zhang

W

, et al.

Integrated bioinformatics analysis reveals key candidate genes and cytokine pathways involved in COVID-19 after rhinovirus infection in asthma patients

.

Med Sci Monit

.

2020

;

26

:

e928861

.

95.

Blank

U

,

Karlsson

S

.

TGF-beta signaling in the control of hematopoietic stem cells

.

Blood

.

2015

;

125

(

23

):

3542

-

3550

.

96.

Sullivan

KD

,

Lewis

HC

,

Hill

AA

, et al.

Trisomy 21 consistently activates the interferon response

.

Elife

.

2016

;

5

:

e16220

.

97.

Bauvois

B

,

Pramil

E

,

Jondreville

L

,

Quiney

C

,

Nguyen-Khac

F

,

Susin

SA

.

Activation of interferon signaling in chronic lymphocytic leukemia cells contributes to apoptosis resistance via a JAK-Src/STAT3/Mcl-1 signaling pathway

.

Biomedicines

.

2021

;

9

(

2

):

188

.

98.

Talpaz

M

,

Mercer

J

,

Hehlmann

R

.

The interferon-alpha revival in CML

.

Ann Hematol

.

2015

;

94

(

suppl 2

):

S195

-

S207

.

99.

Galbraith

M

,

Rachubinski

A

,

Smith

K

, et al.

Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition

.

Sci Adv

.

2023

;

9

(

26

):

eadg6218

.

100.

Huggard

D

,

Kelly

L

,

Ryan

E

, et al.

Increased systemic inflammation in children with Down syndrome

.

Cytokine

.

2020

;

127

:

154938

.

101.

Mei

Y

,

Ren

K

,

Liu

Y

, et al.

Bone marrow-confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia

.

J Clin Invest

.

2022

;

132

(

17

):

e152673

.

102.

Zhou

X

,

Li

Z

,

Zhou

J

.

Tumor necrosis factor alpha in the onset and progression of leukemia

.

Exp Hematol

.

2017

;

45

:

17

-

26

.

103.

Yamashita

M

,

Passegue

E

.

TNF-alpha coordinates hematopoietic stem cell survival and myeloid regeneration

.

Cell Stem Cell

.

2019

;

25

(

3

):

357

-

372.e7

.

104.

Come

C

,

Balhuizen

A

,

Bonnet

D

,

Porse

BT

.

Myelodysplastic syndrome patient-derived xenografts: from no options to many

.

Haematologica

.

2020

;

105

(

4

):

864

-

869

.

105.

Rea

IM

,

Gibson

DS

,

McGilligan

V

,

McNerlan

SE

,

Alexander

HD

,

Ross

OA

.

Age and age-related diseases: role of inflammation triggers and cytokines

.

Front Immunol

.

2018

;

9

:

586

.

106.

Cook

EK

,

Izukawa

T

,

Young

S

, et al.

Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis

.

Blood Adv

.

2019

;

3

(

16

):

2482

-

2486

.

107.

Cook

EK

,

Luo

M

,

Rauh

MJ

.

Clonal hematopoiesis and inflammation: partners in leukemogenesis and comorbidity

.

Exp Hematol

.

2020

;

83

:

85

-

94

.

108.

Ganan-Gomez

I

,

Bijender

K

,

Sevilla

J

, et al.

Mutant natural killer cell dysfunction enables the immune escape of premalignant MDS Ccll clones

.

Blood

.

2023

;

142(suppl 1)

:

514

-

516

.

109.

Li

Y

,

Kong

W

,

Yang

W

, et al.

Single-cell analysis of neonatal HSC ontogeny reveals gradual and uncoordinated transcriptional reprogramming that begins before birth

.

Cell Stem Cell

.

2020

;

27

(

5

):

732

-

747.e7

.

110.

Olson

TS

,

Dickerson

KE

,

Nakano

TA

, et al. Monosomy 7 predisposition syndromes overview. In:

Adam

MP

,

Feldman

J

,

Mirzaa

GM

, eds.

GeneReviews

.

University of Washington, Seattle

;

2021 Jun 10

:

1993

-

2024

.

111.

Jotte

MRM

,

McNerney

ME

.

The significance of CUX1 and chromosome 7 in myeloid malignancies

.

Curr Opin Hematol

.

2022

;

29

(

2

):

92

-

102

.

112.

Inaba

T

,

Honda

H

,

Matsui

H

.

The enigma of monosomy 7

.

Blood

.

2018

;

131

(

26

):

2891

-

2898

.

113.

Mori

M

,

Kubota

Y

,

Durmaz

A

, et al.

Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets

.

Leukemia

.

2023

;

37

(

10

):

2082

-

2093

.

114.

Craver

BM

,

El Alaoui

K

,

Scherber

RM

,

Fleischman

AG

.

The critical role of inflammation in the pathogenesis and progression of myeloid malignancies

.

Cancers (Basel)

.

2018

;

10

(

4

):

104

.